From reading about clinical studies on various chronic diseases, I get a sense that increasing lifespan is rarely the primary objective of these studies, and instead they focus on surrogate markers, like blood pressure or blood sugar. Is it generally important for a drug to have a reduced mortality compared to placebo for it to be approved by FDA, etc?


Your Answer

By clicking “Post Your Answer”, you agree to our terms of service and acknowledge you have read our privacy policy.

Browse other questions tagged or ask your own question.